Objective: To compare the efficiency of acute-phase outpatient electroconvulsive therapy (ECT), maintenance ECT, and inpatient ECT regarding completion of scheduled treatments.
Background: Psychiatric research suggests a trend toward greater use of outpatient ECT and that this modality may offer certain advantages over inpatient ECT. Possible concerns about outpatient ECT may be uncompleted treatments due to transportation problems, forgotten appointments, noncompliance with NPO status, or other variables more easily controlled in the inpatient setting. In addition, without the constant monitoring offered by the hospital setting, physicians prescribing outpatient ECT may less successfully gauge the number of required treatments.
Methods: Completion rates of all scheduled ECTs in a tertiary care hospital setting were monitored prospectively for 8 months. Completed treatment totals were estimated by numbers of outpatient treatments billed for, institutional policy prohibiting charges for missed appointments. Outpatients scheduled for more than 1 treatment per week were considered acute-phase patients; maintenance therapy was defined as 1 or fewer treatments per week.
Results: Of 257 scheduled outpatient maintenance treatments, 91% were completed compared with 65% of 456 scheduled inpatient treatments. This difference was statistically significant (P < 0.0001; chi2 = 59.6; df = 1). Completion rate of acute outpatient treatments was 62% of 78 scheduled, showing a statistically significant difference from that of maintenance ECT (P < 0.0001; chi2 = 39.1; df = 1). No significant difference was detected between the completion rates of inpatient and acute outpatient ECT.
Conclusions: These findings suggest that the efficiency of maintenance ECT is high, comparing favorably with that of convulsive therapy for the acutely ill, and further support maintenance ECT as a useful and cost-effective modality.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00124509-200403000-00006 | DOI Listing |
Can J Psychiatry
November 2024
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Objective: Electroconvulsive therapy (ECT) is an evidence-based treatment for schizophrenia when anti-psychotic medications do not sufficiently control symptoms of psychosis or rapid response is required. Little is known about how it is used in routine clinical practice. The aim of this study was to identify the association of demographic and clinical characteristics with administration of ECT for schizophrenia spectrum disorders (SSD).
View Article and Find Full Text PDFPharmacotherapy
October 2024
Houston Methodist Hospital, Houston, Texas, USA.
Asian J Psychiatr
October 2024
School of Nursing, Peking University, Beijing, China. Electronic address:
Background: Major Depressive Disorder (MDD) affects 350 million people worldwide. Electroconvulsive therapy (ECT) is effective, yet research on cognitive assessments post-treatment is lacking. This study systematically reviews and meta-analyzes the effectiveness of cognitive assessment tools post-ECT to optimize MDD treatment.
View Article and Find Full Text PDFMult Scler Relat Disord
October 2024
Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Neurology Outpatient Clinic, De Boelelaan 1118, Amsterdam 1081 HV, the Netherlands.
Background: Several studies reported lower drug concentrations with subcutaneous natalizumab compared to intravenous natalizumab. With the emergence of extended interval dosing, gaining more insight into lower concentrations after subcutaneous administration is essential.
Methods: We compared serum trough concentrations between subcutaneous and intravenous administration within a matched cohort (n = 50).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!